IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The BRAKE-AF Study is a phase III, randomised, controlled, multicentric, open-label clinical
trial to prove the noninferiority of ivabradine versus digoxin in the treatment of permanent
atrial fibrillation. The total duration of the study is 3 years, with 24 months of enrolment,
treatment and follow-up.
Phase:
Phase 3
Details
Lead Sponsor:
Adolfo Fontenla
Collaborators:
Carlos III Health Institute Spanish Clinical Research Networt (SCReN)